Advertisement

SAB Biotherapeutics, Inc. SABS

Set alert

Price alert · SABS

All alert types
3.35 USD +0.12 +3.72%

At close · Oct 30

3.35 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
3.34 × 5
Ask
3.36 × 2
3.11 Day range 3.37
2.49 52-week range 4.59
YTD
-10.43%
1 year
+11.30%
Open
3.20
Prev close
3.23
Mkt cap
304.80M
Vol
741.05K
Avg vol
536.84K
EPS
-1.29
P/E
0.00
Div yield
0.00%
More statistics
Low
3.11
High
3.37
Forward P/E
-1.56
Beta
0.64
Short ratio
1.22
Inst. own
34.25%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
3.29
200-d avg
3.35
1y target
12.40

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SABS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Net Loss → Expenses: $11.39MExpenses → Gross Loss: $671.01KExpenses → Selling, General & Admin: $1.71MExpenses → Research & Development: $7.63MExpenses → Interest Expense: $70.88KExpenses → Other Expenses: $1.31MRevenue → Cost of Revenue: $114.70KNet Loss$11.39MCost of Revenue$785.71KExpenses$11.39MGross Loss$671.01KSelling, General & Admin$1.71MResearch & Development$7.63MInterest Expense$70.88KOther Expenses$1.31MRevenue$114.70K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

SABS quarterly income statement
23.38M
16.17M
7.21M
-23.38M
62.00K
-22.49M
-22.49M
-22.49M
-22.49M
-0.28
-0.28
-0.28
-22.43M
-22.43M
79.75M
79.75M

Balance sheet

SABS quarterly balance sheet
8.27M
8.27M
199.71M
94.36M
105.35M
107.94M
19.58M
238.21M
641.00K
5.13M
11.71M
4.49M
23.43M
-152.25M
-930.00K
214.78M
214.78M
130.27M
5.13M
11.72M
3.85M

Cash flow

SABS quarterly cash flow
834.33K
2.36M
-12.25M
-1.58M
1.86M
-38.61K
-4.88M
-3.30M
-9.84M
107.27K
7.25M
Advertisement